In Q1 2026, 3 tracked hedge funds held Agomab Therapeutics Nv. 3 funds initiated new positions. Hedge fund interest remained limited.
| # | Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|---|
| 1 | Cormorant Asset Management | 2,465,348 | 25.86M | 1.30% | NEW |
| 2 | Seven Grand Managers LLC | 200,000 | 2.10M | 0.14% | NEW |
| 3 | Millennium Management LLC | 95,233 | 998,994 | 0.00% | NEW |